Greaves Cotton, for instance, has converted half its holding into commercial real estate (a multiplex) while Elpro plans to follow suit by developing half its 37-acre land at Chinchwad.
Rohm and Haas, one of the largest speciality material manufacturers in the world, plans to invest $100 million (about Rs 410 crore) in India to develop manufacturing and research and development facilities.
According to senior RIL executives, more than half the work has been completed on the pipeline, which will transport gas from the KG basin to the RIL refinery at Jamnagar.
A study by a Swedish University has accused India's Active Pharmaceutical Ingredient (API) manufacturers of causing alarming levels of environmental pollution and threatening the region's flora and fauna.
Like the US, India too has a sub-prime market and it is booming. The success of early entrants like Citi Financial and GE Money has encouraged several others to enter the consumer lending business, nearly half of which is a sub-prime market.
Even as some major global pharmaceutical majors like Novartis say India's patent laws are weak and a hurdle to their investment plans for the country
If a science graduate or a B Pharma degree was the minimum requirement for the job of medical representative some years ago, acute manpower crisis and inability to penetrate rural areas have forced the phramaceutical industry
Even if you assume a higher return fare of Rs 40,000, the yield will still be lower than the costs.
As competition hots up, airlines are doling out freebies to wean away customers.
Besides Novartis, the other companies are Roche, J&J, Glaxo and Astrazeneca.
P B Jayakumar caught up Dr Reddy's chairman K Anji Reddy and tried to balance science and religion. And yes, there is also the question of choosing between the son and the son-in-law.
Mumbai-based pharma major Lupin will invest over Rs 200 crore (Rs 2 billion) this year to create additional manufacturing capacities.
Not too long ago, authorised generics were used by the big US-based pharmaceutical companies to thwart competition from makers of generic drugs
Mukesh will invest Rs 25,000 crore in setting up an SEZ in Navi Mumbai
"Why should we panic? Today, the market is at a higher level. Even a 400 points fall is less than 3 per cent of the market," said Anoop S Kumar, a retail investor who works for a public sector bank. He's not alone who thinks so.
RIL is likely to take about six months to one year to estimate the oil and gas reserves available from the new discovery.
Five global engineering and power equipment construction majors are in the race to bag the Rs 8,000 crore
The list, posted on a website link launched by the US regulator, includes ABB, HSBC, Nokia, Unilever, Cadbury, Total and Siemens among others.
The US Food and Drug Administration has tightened rules for selling dietary supplements in the US market, making compliance with current good manufacturing practices mandatory for manufacturers.
Indian drug major Nicholas Piramal India Ltd is likely to be among the first pharmaceutical companies worldwide to develop drugs isolated from the flora and fauna of Antarctica.
